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Abstract: we recently discovered that peptide dendrimers such as G3KL 
((KL)8(KKL)4(KKL)2KKL, K = branching L-lysine) exert strong activity against Gram-
negative bacteria including Pseudomonas aeruginosa, Acinetobacter baumannii and 
Escherichia coli. Herein we report a detailed mechanistic study using fluorescence labeled 
analogs bearing fluorescein (G3KL-Fluo) or dansyl (G3KL-Dansyl), which show a similar 
bioactivity profile as G3KL. Imaging bacterial killing by super-resolution stimulated 
emission depletion (STED) microscopy, time-lapse imaging and transmission electron 
microscopy (TEM) reveals that the dendrimer localizes at the bacterial membrane, induces 
membrane depolarization and permeabilization, and destroys the outer leaflet and the inner 
membrane. G3KL accumulates in bacteria against which it is active, however it only weakly 
penetrates into eukaryotic cells without inducing significant toxicity. G3KL furthermore 
binds to lipopolysaccharide (LPS) and inhibits LPS induced release of TNF-α by 
macrophages similarly to polymyxin B.  Taken together, these experiments show that G3KL 
behaves as a potent membrane disruptive antimicrobial peptide.   
Keywords: bacterial membranes, STED microscopy, Pseudomonas aeruginosa, cell 
penetrating peptides, polymyxin B   
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The number of human infections caused by multidrug-resistant bacteria consistently increased 
since the 1980s. In 2013, multidrug-resistant bacteria A. baumannii and P. aeruginosa were 
listed among the top 18 antibiotic resistance threats by the United States CDC (Center for 
Disease Control and Prevention). In February 2017, both pathogens, together with 
Enterobacteriaceae were considered as the most critical human pathogens by World Health 
Organization for which new antibiotics are urgently needed.1  
 One of the approaches to address the challenge of multidrug resistant bacteria consists 
in designing new analogs of antimicrobial peptides (AMPs), also called host-defense peptides, 
a broad class of natural products occurring in microorganisms, plants and animals as 
components of innate immunity, most of which consist of cationic and hydrophobic residues 
folding into amphiphilic and membrane disruptive α-helices in a membrane environment.2–8 
By exploring synthetic peptides with unusual branched topologies,9 we discovered that 
peptide dendrimers composed of lysine and leucine, in particular dendrimer G3KL, can exert 
strong antimicrobial effects against multidrug resistant P. aeruginosa and A. baumannii  
including multidrug resistant clinical isolates while showing negligible haemolysis and 
excellent stability towards serum proteolytic degradation, and thus represent a new 
opportunity to fight these bacteria (Scheme 1).10,11 G3KL furthermore had a positive impact 
on burn wound-healing processes by a pro-angiogenic effect,12 displayed significant 
inhibitory effects on biofilms,13 and proved to be amenable to optimization towards in vivo 
use by a virtual screening guided approach.14,15  
 Although structural studies with G3KL and related dendrimers did not provide any 
evidence of a segregation of hydrophobic and cationic residues towards an amphiphilic 
structure, we observed that G3KL disrupts fluorescein-loaded large unilamellar vesicles 
consisting of the anionic lipid phosphatidyl glycerol and which mimic bacterial membranes 
but no effect on vesicles consisting of phosphatidyl choline mimicking the eukaryotic cell 
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membrane.16,10 Membrane disruption was also supported by typically fast killing kinetics and 
by transmission electron microscopy (TEM) images showing disrupted cellular structures.14,17 
LPS deletion mutants of P. aeruginosa further revealed that G3KL remained active on all 
variants independent of the LPS composition of the bacterial outer membrane.10 Inspired by 
microscopic studies with fluorescence labeled analogs of polymyxin B (PMB, a cyclic 
antimicrobial peptide),18 cathelicidins (a family of linear AMPs)19,20 and antimicrobial peptide 
polymers,21 we herein set out to use fluorescence imaging to investigate the mechanism of 
bacterial killing by antimicrobial peptide dendrimer G3KL in more detail.  
 
Results and Discussion 
Fluorescent probes G3KL-Fluo and G3KL-Dansyl maintain the activity profile of G3KL  
To obtain fluorescence labeled analogs of G3KL we extended its sequence by an additional 
side-chain alloc protected lysine residue as the first core residue.17 After completion of the 
SPPS sequence,22,23 we selectively removed the alloc group and coupled the liberated -amino 
group to 5(6)-carboxyfluorescein, dansyl chloride or rhodamine B. Deprotection of the N-
terminal Fmoc groups, side-chain deprotection and cleavage from the solid support followed 
by RP-HPLC purification yielded dendrimers G3KL-Fluo, G3KL-Dansyl and G3KL-Rho 
(Table 1, Figure 1). For comparison in experiments with eukaryotic cells we also considered 
the previously reported cell penetrating dendrimer D1 in it’s fluorescein labeled form, which 
has a similar sequence but shows no antimicrobial activity.24    
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Table 1. Synthesis and antimicrobial activity of fluorescent G3KL analogs and control cell penetrating 
dendrimer D1.a)  
Cpd. Sequenceb) Yieldc) 
mg (%) 
MSd) 
calcd/obs. 
MW of 
TFA salte) 
P. aeruginosa 
PAO1 
MIC (µg/mL) 
E. coli 
W3110 
MIC 
(µg/mL) 
A. baumannii 
ATCC19606 
MIC (µg/mL) 
G3KL (KL)8(KKL)4(KKL)2KKL 82.3 (12) 4530.39/ 4531.39 7152.39 4 4-8 8 
G3KL-Fluo (KL)8(KKL)4(KKL)2KKLK(Fluo) 46.3 (6) 5017.52/ 5017.54 7754.50 4 2 4 
G3KL-Dansyl (KL)8(KKL)4(KKL)2KKLK(Dansyl) 47.5 (6) 4892.52/ 4892.53 7628.52 4 4 8 
G3KL-Rho (KL)8(KKL)4(KKL)2KKLK(Rho) 19.7 (2) 5084.69/ 5083.71 7820.69 16 8 8 
D1 (RL)8(KRL)4(KKK)2KGYK(Fluo) 48 (5.2) 5362.52/5362.52 7938.52 >64 >64 >64 
aMinimal inhibitory concentration (MIC) values in μg/mL were determined by serial ½ dilution in MH medium. None of the 
compounds showed any activity (MIC > 64 µg/mL) on K. pneumoniae. bOne letter code is for amino acids. Branching 
diamino acids are in italics. All peptide dendrimers are carboxamides (CONH2) at the C-terminus. cYields given for RP-
HPLC purified product. dMass calcd. for M+, observed by positive-ion mode ESI as M+ see SI for details. e) Molecular 
weight of trifluoroacetate salt, used in all weight measurements for activities.  
 
 
Figure 1. Synthesis of G3KL analogs. Conditions: (a) Solid phase peptide synthesis (SPPS): i) 20% v/v piperidine 
20 min. 25°C, then wash DMF 3×, MeOH 3× and DCM 3×; ii) FmocAAOH (5 equiv), Oxyma (5 equiv), DIC (7 
equiv), NMP, RT, 1.5 h (coupling number and time increased with peptide dendrimer generation). (b) i) Alloc 
deprotection with Pd(PPh3)4 (0.25 equiv), PhSiH3 (25 equiv), DCM, 2× 45 min; ii) coupling of the fluorophores to 
the peptide dendrimer: Dansyl chloride (7 equiv), TEA (7 equiv) in DCM, 5(6)-carboxyfluorescein (7 equiv) and 
rhodamine B (7 equiv) with Oxyma/DIC in NMP. (c) TFA/TIS/H2O (95:2.5:2.5), 4h and HPLC purification. 
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Figure 2. Bacteria killing assay and TEM imaging with G3KL and fluorescence labeled analogs. A. Static time-
kill assay showed a fast decline in P. aeruginosa bacterial burden at 37°C in MH medium at 2× MIC for G3KL 
(8 μg/mL), G3KL-Fluo (8 μg/mL) and G3KL-Dansyl (8 μg/mL). The assay was performed two times in 
triplicates. b. TEM imaging of 109 CFU/mL (OD600 = 1.0) of P. aeruginosa exposed to G3KL, G3KL-Fluo or 
G3KL-Dansyl. All bacteria were exposed to the same concentration of 40 μg/mL of dendrimer for 60 min in M63 
minimal medium. The arrows represent different damages to the bacterial cells. Red: aggregation inside the cell. 
Blue: bacterial shape change. Light blue: visible broken inner membrane. Enlarged TEM images can be found in 
the supporting information.  
 
Minimal inhibitory concentration (MIC) profiling showed that G3KL-Fluo and G3KL-
Dansyl had essentially the same activity as G3KL against P. aeruginosa, E. coli, and A. 
baumannii, while G3KL-Rho has reduced activity and was therefore not investigated further 
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(Table 1). Killing kinetics on P. aeruginosa at an initial inoculum of ~106 cfu/mL showed that 
G3KL-Fluo and G3KL-Dansyl behaved similarly to G3KL.14  All three dendrimers induced 
rapid and significant decline (> 99%) in bacterial burden at 2 × MIC and effectively killed the 
bacteria after 2 hours (Figure 2A). Furthermore, transmission electron microscopy (TEM) 
images of P. aeruginosa cells exposed to the compounds at 10  MIC for 1 hour showed that 
both probes disrupted bacterial cells similarly to unlabeled G3KL by causing a change in 
bacterial shape (or peptidoglycan) (blue arrow), a visible and broken inner membrane (light 
blue arrow), vesicle-like structures (yellow arrow) and some aggregation inside the cells (red 
arrow) (Figure 2B).   
 
Super-resolution and confocal microscopy indicate rapid entry of G3KL-Fluo and G3KL-
Dansyl into P. aeruginosa cells 
G3KL-Fluo exhibited a very bright fluorescence suitable for stimulated emission depletion 
(STED) nanoscopy to track its interaction with bacterial cells. We incubated P. aeruginosa 
cells (109 CFU/mL) with G3KL-Fluo (10 × MIC, 40 µg/mL) in M63 minimal medium and 
fixed cells for 2, 5, 15 and 30 minutes. At 2 min. G3KL-Fluo was localized at the periphery 
and inside bacteria. Fluorescence increased at 5 min. with a slightly more intense fluorescence 
at the bacterial septum of dividing cells, and after 15 minutes bacteria were entirely filled with 
the compound (Figure 3A). This experiment showed that G3KL-Fluo rapidly bound and 
entered bacterial cells.   
In a second imaging experiment by standard confocal imaging, we used G3KL-
Dansyl in combination with the lipophilic dye FM4-64 reported to stain the outer25 or the 
inner bacterial membrane.26 The two dyes have different fluorescence excitation and emission 
wavelength allowing to track the localization of the dendrimer and possible damages to the 
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cell membrane simultaneously.  FM4-64 indeed stained the bacterial membrane of P. 
aeruginosa cells when incubated alone (both inner and outer membrane were stained). 
Addition of G3KL-Dansyl at 40 µg/mL followed by 15 minutes incubation and fixation 
resulted in FM4-64 being dispersed outside and inside the bacteria (Figure 3B). We observed 
the same effect when first treating with G3KL-Dansyl followed by staining with FM4-64 
(Figure S1). We interpret the vesicle-like structures stained by FM4-64 (yellow arrows) 
floating outside of the bacteria (green arrows) as the remains of the outer membrane, while 
the dispersed dye inside bacteria should mark broken inner membrane, in line with the effects 
of G3KL-Dansyl on bacteria observed by TEM (Figure 3B and Figure S2). These membrane 
disruptive effects are much stronger than those reported when using FM4-64 to track the 
effect of PMB on K. pneumoniae cells,18 and of peptide-appended PAMAM dendrimers21 and 
multivalent proline peptides on E. coli cells.27 
 
Figure 3. A. Superresolution images of 109 CFU/mL (OD600 1.0) of P. aeruginosa exposed to 40 μg/mL of G3KL-
Fluo for 2, 5, 15 and 30 min. Scale bars, 1 μm. The images are representative of two independent experiments. B.  
Confocal microscopy of 109 CFU/mL (OD600 1.0) of P. aeruginosa incubated with FM4-64 and treated with 
G3KL-Dansyl for 15 min.  
 
Time-lapse imaging shows that G3KL-Fluo enters and permeabilizes P. aeruginosa cells  
The STED microscopy images above suggested that G3KL-Fluo rapidly entered bacterial 
cells, however images were taken at selected time points with fixed cells. To investigate the 
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phenomenon closer, we tracked the entry of G3KL-Fluo into live P. aeruginosa cells in real 
time by time-lapse confocal imaging similarly to an experiment reported for the AMP 
cathelicidin cath-2.20 We performed the experiment in presence of propidium iodide (PI), 
which becomes fluorescent when binding to DNA and could be used to test whether the 
dendrimer permeabilized the cells.  
 To circumvent the swimming capacity of the bacteria in aqueous medium, we trapped 
the bacteria inside an M63 agarose pad.20 After adding additional medium to the agarose pad, 
we adjusted the focus on several bacteria, added PI, initiated the movie, and after 6 min. 
added our dendrimer. G3KL-Fluo immediately started to stain the bacterial surface and 
within another 5 min. had entirely diffused inside the cells, confirming images obtained by 
STED microscopy (Figure 4A). Furthermore, we observed that PI, which was initially not 
visible, also diffused into the cells, however with a delay of approximately 5 min. compared 
to the dendrimer. This data indicated that the peptide dendrimer diffused or translocated 
through the membrane into the cytoplasm and triggered permeabilization of bacterial cells, 
probably through damages at both the outer and inner membrane as observed by TEM (Figure 
2B and S2). As a comparison to G3KL-Fluo, we also performed time-lapse imaging with 
unlabeled G3KL in the presence of PI. Indeed, PI was rapidly observed within the cells, 
leading to overexposure of fluorescence within 5 min. after addition of G3KL. This 
experiment showed that labeled and unlabeled dendrimers permeabilized P. aeruginosa cells 
to a similar extent (Figure S3). These permeabilization effects are similar to those reported for 
the antimicrobial peptide cath-2.20   
 Remarkably, the movie indicated that the fluorescence of G3KL-Fluo slightly 
decreased in the center of the bacteria at 15 min, which might indicate fluorescence quenching 
due to binding of the dendrimer to DNA (Figure 4A/B).28,29 Consistent with this hypothesis, 
incubating G3KL-Fluo with plasmid DNA (pEt25rsl)30 induced significant quenching of 
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fluorescence at N/P = 0.5 and below (excess plasmid, Figure 4C). Quenching reflects a direct 
binding interaction between the dendrimer and DNA, as evidenced by the decrease in 
unbound DNA upon addition of unlabeled G3KL above N/P = 2.5 as measured the 
intercalating dye PicoGreen (Figure 4D and S4).31  
 
Figure 4. A. Time-lapse imaging of single cell of P. aeruginosa exposed to G3KL-Fluo at 10x MIC and the 
nucleic acid selective probe propidium iodide. Scale bar, 1 μm. B. Mean fluorescence intensity of G3KL-Fluo 
and PI extracted by using Image J software. C. Quenching effect of G3KL-Fluo in the presence of the pEt25rsl 
plasmid. D. Interaction of G3KL and PMB with pEt25rsl plasmid by PicoGreenTM assay. E. Membrane 
permeability changes of P. aeruginosa induced by PMB, G3KL and Tobramycin by NPN assay. F. Membrane 
depolarization of P. aeruginosa cells with PMB, G3KL and Tobramycin by DiSC3(5) assay. All experiments were 
performed at least two times in triplicates.  
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G3KL permeabilizes the outer membrane and depolarizes the inner membrane of P. 
aeruginosa cells. 
We performed two additional experiments to measure the effect of our dendrimers on the 
outer and inner membrane of P. aeruginosa cells in comparison to PMB, a membrane active 
antimicrobial cyclic peptide known to act at the lipopolysaccharide (LPS) in the outer leaflet 
of the bacterial membrane32 and tobramycin, an aminoglycoside antibiotic targeting the 
ribosome that does not affect membrane properties.33  
 In the first experiment, we used the N-phenylnaphthylamine (NPN) assay, in which the 
NPN dye becomes strongly fluorescent in contact with a phospholipid bilayer, indicating 
permeabilization of the outer membrane34 PMB was the best permeabilizer exhibiting high 
fluorescence intensity of NPN at very low concentration of 1.25 µg/mL, reproducing earlier 
reports in Gram-negative bacteria,35 while only a very weak signal was observed with 
tobramycin. While the NPN assay could not be recorded with G3KL-Fluo and G3KL-Dansyl 
due to interference with fluorescence excitation and emission wavelengths (Figure S5), the 
unlabeled dendrimer G3KL showed a strong NPN signal at 2.5 µg/mL similarly to PMB, 
confirming the permeabilization effect on the outer membrane observed in the time-lapse 
experiment with PI (Figure 4E).  
 In the second experiment we used the membrane potential-sensitive dye DiSC3(5) to 
evaluate depolarization of the cytoplasmic (inner) membrane.36 In this assay G3KL exhibited 
a robust response indicating strong cytoplasmic membrane depolarization at low 
concentration (Figure 4F, Figure S6). In contrast, PMB and tobramycin only showed a weak 
effect, indicating that these antibiotics do not affect the inner membrane of P. aeruginosa. In 
the case of PMB the absence of inner membrane depolarization is consistent with the fact that 
the primary interaction site of PMB is Lipid A located at the outer membrane.32  
11 
 
G3KL-Fluo and G3KL accumulate in bacteria 
Since the microscopy studies above showed that G3KL-Fluo bound and internalized into 
bacteria, we were curious to estimate the amount of dendrimer taken up by the cells. We 
quantified cellular uptake as the difference between total G3KL-Fluo added and unabsorbed 
dendrimer measured by the fluorescence remaining in the supernatant after high speed 
centrifugation of the bacteria. For P. aeruginosa cells at OD600 1.0 in M63 medium, we found 
that at an initial concentration of 40 μg/mL G3KL-Fluo 80% of the dendrimer was absorbed 
after 5 min. After 15 min incubation, fluorescence in the supernatant was close to background, 
indicating complete uptake by the bacteria (Figure 5A). Repeating the experiment with higher 
starting concentration of G3KL-Fluo showed that the maximal uptake corresponded to 32-64 
µg/mL G3KL-Fluo in the supernatant (Figure S8).   
 Under the same conditions, uptake was also quantitative with A. baumannii and at 
60% with E. coli, both of which are sensitive to G3KL-Fluo, while no significant uptake was 
observed for methicillin-resistant Staphylococcus aureus and Klebsiella pneumoniae, against 
which G3KL-Fluo was inactive (Figure 5B). Uptake of the dendrimer was confirmed by 
confocal microscopy of A. baumannii and E. coli treated with 40 µg/mL of G3KL-Fluo, 
which showed that the dendrimer not only binds to the cell surface but also penetrates the 
cells as in the case of P. aeruginosa discussed above (Figure 3 and S7). These experiments 
showed that G3KL-Fluo only accumulated in bacteria against which it was active. The 
absence of uptake by S. aureus probably reflects the very different composition of the 
bacterial cell envelope of Gram-positive versus Gram-negative bacteria,37 while in the case of 
K. pneumoniae uptake of G3KL-Fluo might be blocked by the polysaccharide capsule.38  
 To compare whether labeled and unlabeled compounds were absorbed in the same 
range, we treated the bacteria (109 CFU/mL) with G3KL, G3KL-Fluo and PMB at various 
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concentrations (32, 64 and 128 μg/mL) in M63 minimal medium. After 60 minutes, we 
centrifuged the bacteria at maximal speed, isolated the supernatant and used it as the starting 
concentration for MIC determination to determine the remaining antibacterial activity and 
therefore the amount of compound left in the supernatant in comparison with a reference 
untreated sample in the same medium. Note that while the activity of PMB decreased from 
0.25 μg/mL in MH to 4 μg/mL in M63 due the presence of magnesium in the latter medium,39 
the activity of G3KL and G3KL-Fluo was the same (4 µg/mL) in both media (Table S1).  
 
Figure 5. Quantification of G3KL-Fluo taken up by 109 CFU/mL (OD600 1.0) of P. aeruginosa cells. A. 
Fluorescence measurement of the supernatant from the treated samples at 40 µg/mL. B. Measurement of the 
excess fluorescence in the supernatant after exposing the bacteria P. aeruginosa, MRSA, K. pneumoniae, E. coli 
and A. baumannii to G3KL-Fluo at 40 µg/mL in M63 medium for 60 min. C. Starting and Apparent 
Concentration of G3KL, G3KL-Fluo and PMB in P. aeruginosa PAO1 after 60 min at 37 °C. D. Total amount 
of G3KL, G3KL-Fluo and PMB in 1 g of bacteria. All experiments were performed two times in triplicates. 
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The results showed that labeled and unlabeled peptide dendrimers were taken up in 
comparable amounts by P. aeruginosa cells (Figure 5C). The amounts of 64 μg/mL G3KL-
Fluo and 56-64 μg/mL G3KL for 109 CFU/mL determined by the MIC method precisely 
matched the uptake measured by fluorescence with G3KL-Fluo (Figure S8).  Bacterial uptake 
of PMB (40-64 μg/mL) by P. aeruginosa was comparable to that of our dendrimers and 
matched the data reported for the uptake of antimicrobial peptide PMAP-23 by high density 
E. coli.40 Considering the dimensions of P. aeruginosa cells estimated by TEM to determine 
bacterial volume (Figure S2) and assuming a density of 1 g/mL for the bacterial cell, these 
data implied that these antibacterial compounds accumulate in P. aeruginosa up to 5-10% of 
bacterial weight, corresponding to at least a 100-fold concentration from the medium (Figure 
5D).  
G3KL-Fluo and G3KL penetrate but are non-toxic and do not accumulate in 
mammalian cells 
To test if G3KL-Fluo had cell penetrating properties in mammalian cells, we measured 
cellular uptake in HeLa and CHO cells by imaging flow cytometry (ImageStream) in 
comparison to D1, a peptide dendrimer optimized for cellular uptake,24  and the cell 
penetrating linear peptides TAT and R9 (nona-arginine), all of which were labeled with 
fluorescein.41,42 Analysis of cellular uptake by flow cytometry showed that G3KL-Fluo 
entered cells to the same level as TAT, corresponding to 10% uptake in HeLa and 30% in 
CHO cells compared to D1 and 20% compared to R9 peptide in both cell lines (Figure 6A, 
Figure S10). Quantifying uptake by the difference method used above with bacteria showed 
that the amount of compound actually taken up by the cells was not significant with any of the 
four compounds tested (Figure 6B). We also found that G3KL-Fluo and G3KL were not 
toxic to both cell lines, with IC50 values well above their MIC values against bacteria (IC50 = 
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135 μM; ~1,000 µg/mL, Figure 6C/D). On the other hand, G3KL-Dansyl showed significant 
toxicity (IC50 = 15 μM; ~107 μg/mL) in both cell lines, showing that minor structural changes 
may affect activity even in the relatively large peptide dendrimer molecule. 
 
Figure 6. A. Quantification of cell penetrating peptide and peptide dendrimers in HeLa and CHO cells at 10 μM 
for 60 minutes in the presence of DMEM containing 1% BSA at 37°C and 5% CO2 by imaging flow cytometry. 
B. Measurement of the excess of fluorescence in the supernatant after exposing HeLa and CHO cells to the cell 
penetrating peptide and peptide dendrimers at 10 μM for 60 minutes. Cytotoxicity of G3KL, G3KL-Fluo and 
G3KL-Danysl in HeLa (C) and CHO (D) cells in DMEM containing 10% FBS. All experiments were 
performed two times in triplicates. 
 
G3KL binds and inactivates Endotoxin lipopolysaccharide (LPS), and vice versa 
Most cationic AMPs including PMB and the cathelicidin family of AMPs bind to the 
endotoxin lipopolysaccharide (LPS), which is the major component of the outer membrane of 
Gram-negative bacteria,43 and thereby have the beneficial effect to inhibit the release of pro-
inflammatory cytokines such as TNF-α from macrophages induced by binding of LPS to toll-
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like receptor TLR4,44,45 and thereby to attenuate septic shock.46–48 We obtained a first 
evidence of a binding interaction between our dendrimers and LPS by a quenching effect of 
LPS on G3KL-Fluo probably caused by autoquenching due to concentration upon binding to 
LPS aggregates (Figure 7A).49 Evidence for unlabeled G3KL binding to LPS was next 
obtained by tracking LPS induced expression of intracellular TNF-α in mouse macrophages 
RAW264.7 by Western blot (WB, Figure 7B). Indeed, G3KL (10 µM, 72 µg/mL) blocked 
TNF-α expression induced by LPS (0.1 μg/mL) when the experiment was performed in 
DMEM containing 1% FBS, similarly to the effect observed by PMB (10 µM, 14 µg/mL) 
(Figure 7B). When the experiment was performed in the presence of 10% FBS by contrast we 
only observed TNF-α inhibition by PMB as previously reported,50,51 while G3KL was 
inactive, suggesting a weaker and less selective binding to LPS versus serum proteins 
compared to PMB (Figure 7C).  
16 
 
 
 
Figure 7. Fluorescence measurement of G3KL-Fluo at 128 µg/mL mixed with increasing concentrations of 
LPS. The experiment was performed two times in triplicates. (A). Effect of antimicrobial peptide dendrimer 
G3KL and PMB on the expression of inflammatory cytokine TNF-α by Western blot. Total proteins were run on 
12% Bolt Tris Glycine Plus gels in reducing condition (dithiothreitol at 95°C for 5 min). Separated proteins were 
immunoblotted with anti-TNF-α antibody. The immunoreactive bands of TNF-α in RAW264.7 cells treated with 
or without LPS ± the compounds (PMB 14 µg/mL, 10 µM or G3KL, 72 µg/mL 10 µM) for a total time of 3 
hours in DMEM containing 1% FBS (B) or 10% FBS (C). (B) and (C) were performed two times.  
Besides its effect on TNF-α release, the binding interaction between LPS and antimicrobial 
compounds should also result in decreased antimicrobial activity. To test this hypothesis, we 
measured the antibacterial activity of G3KL, PMB and tobramycin on E. coli, P. aeruginosa 
and A. baumannii in the presence of LPS. The presence of a small amount of LPS in the 
medium (5 µg/mL) indeed reduced the antibacterial activity PMB but not of G3KL or 
tobramycin (Table 2, left part). On the other hand, further increasing LPS in the presence of a 
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constant amount G3KL (8 µg/mL) eventually also blocked its activity in all three strains 
tested ([LPS] ≥ 32-64 µg/mL), while tobramycin remained unaffected (Table 2, right part).  
 The data indicated that a 4-fold excess by weight of LPS was necessary to block the 
activity of G3KL, which is comparable to PMB at 0.5 μg/mL losing its activity with 2-4 
μg/mL of LPS. In the case of PMB which carries five positive charges for MW = 1203.5 kDa, 
this stoichiometry corresponds to charge neutralization assuming MW = 10 kDa  for LPS and 
that the serotype used (O111) contains 6-10 negative charges.52 The same applies to G3KL 
when considering acid-base titration indicating that at physiological pH the amino termini are 
present as free base (NH2), while all lysine side chains are protonated (NH3
+), which overall 
corresponds to 15 positive charges for G3KL at pH 7.4 for a MW of 4534.30 kDa (Table 3, 
Figure S11).  
Table 2. Minimum concentration of LPS required to block the activity of PMB and G3KL in E. coli W3110 and 
P. aeruginosa PAO1 and A. baumannii (ATCC19606). 
 
 PMB
a)
 
(-/+ 5 μg/mL LPS) 
G3KL
a)
 
(-/+ 5 μg/mL LPS) 
Tobra
a)
 
(-/+ 5 μg/mL LPS) 
LPS
b)
 
(+ 0.5 μg/mL 
PMB) 
LPS
b)
 
(+ 8 μg/mL 
G3KL) 
LPS
b)
 
(+ 4 or 8 μg/mL 
Tobra) 
E. coli 0.125 / 0.5 4-8 / 8 0.25 / 0.25 2-4* 32-64* > 64* 
P. aeruginosa 0.25 / 2 4 / 4 
 
0.25 / 0.25 
1-2* 64* > 64* 
A. baumannii 0.25 / 2 8 / 8 2 / 2 4-8* 32-64* > 64* 
a) The minimum inhibitory concentration in μg/mL was determined in MH medium. b) The minimum concentration of LPS 
in μg/mL was determined in MH medium containing Polymyxin, G3KL or Tobramycin. * Amount of LPS necessary to 
inhibit the activity of PMB, G3KL, Tobra at 2 × MIC. The experiments were performed at least two times in triplicates. 
 
Table 3. Ratio of molecular charges between G3KL, PMB and LPS.  
 
 
MW[a] Number of charges MW/charges Ratio LPS/compound charge 
G3KL 4534 15 302.3 3.3 – 5.5 
PMB 1204 5 241 4.1 – 6.9 
LPS 10000 6 – 10[b] 1000 - 1666 - 
[a] MW without counter ions in g/mol [b] data from reference52 
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We believe that inactivation by LPS binding might explain the regrowth of P. aeruginosa 
after treatment with PMB often observed in time-kill experiments53 since PMB is usually 
applied in low amounts (0.5 μg/mL). By contrast, the absence of any regrowth in time kill 
experiments with our dendrimers is probably explained by the much higher amounts applied 
(8 μg/mL) which provide excess of antibacterial compound compared to the amount of LPS 
that can be released by bacteria. 
Conclusion 
The fluorescence imaging and mechanistic studies with fluorescence labeled analogs of 
antimicrobial peptide dendrimer G3KL presented above reveal its bacterial killing 
mechanism and show that G3KL behaves as a membrane disruptive AMP against Gram-
negative bacteria. When compared with other AMPs, G3KL disrupts bacterial membranes to 
a larger extent than PMB as observed by TEM14,17 and by confocal microscopy (Figure 3), but 
produces the same overall cell permeabilization effects as cathelicidin cath-2 by time-lapse 
imaging of propidium iodide uptake (Figure 4A-D).20 G3KL furthermore induces a similar 
level of outer membrane permeabilization as cathelicidin PMAP-3654 and PMB by the NPN 
assay (Figure 4E) and in addition depolarizes the inner membrane to the same extent as 
Gramicidin S (Figure 4F).35 The cell-penetrating properties of G3KL (Figure 6) and its LPS 
neutralizing abilities (Figure 7, Table 2-3) are further attributes of typical membrane 
disruptive AMPs.  
 Most strikingly, G3KL accumulates in P. aeruginosa, A. baumannii and E. coli cells, 
against which it is active, but does not accumulate in K. pneumoniae or MRSA, against which 
it is inactive (Figure 5). Our observation of accumulation of our dendrimer G3KL and PMB 
in bacteria, which has also been noted for cathelicidin PMAP-23,40 is probably a general 
feature of membrane disruptive AMPs. We also believe that our observations with G3KL are 
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representative of the mechanism of action of recently reported antimicrobial peptide 
dendrimer analogs of G3KL.14,15,17           
Methods 
Procedures for peptide synthesis, microbiology, cell culture, microscopy, and analytical data 
for all peptides, are described in the supporting information.  
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